High-dose vitamin D therapy and prolonged partial remission of type 1 diabetes — a case report
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Clinical trials demonstrating β-cell protection by high-dose vitamin D supplementation have led to the adoption of adjunctive vitamin D therapy in stage 3 type 1 diabetes (T1D). We present the case of a 12-year-old male child who received high-dose vitamin D therapy from 1-27 months following his diagnosis with T1D. His serum 25-hydroxyvitamin D rose from 25 ng/mL to 65 ng/dL within 3 months and remained >40 ng/mL. Hemoglobin A1c (A1c) decreased from 13.8% at diagnosis to persistently 70% for 24 months, and insulin-dose adjusted A1c (IDAA1c), the clinical marker of partial clinical remission, decreased from 17 to
Fields of Study & Subjects
Diabetes and associated disorders
Vitamin D Research Studies
Diabetes Management and Research
Publication details
- Journal / source
- Frontiers in Endocrinology
- Volume
- 17
- Pages
- 1788049–1788049
- Publication date
- 31 March 2026
- Language
- EN